Publications by authors named "Christa de Winter"

Claim this Profile
P
Preclinical PK and PD studies on 2'-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model.
Hans Heemskerk, Christa de Winter, Petra van Kuik, Niki Heuvelmans, Patrizia Sabatelli

Mol Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3 months mild functional test regime does not affect disease parameters in young mdx mice.
Maaike van Putten, Christa de Winter, Willeke van Roon-Mom, Gert-Jan van Ommen, Peter A C 't Hoen

Neuromuscul Disord· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials.
Linda J Popplewell, Carl Adkin, Virginia Arechavala-Gomeza, Annemieke Aartsma-Rus, Christa L de Winter

Neuromuscul Disord· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Hans Heemskerk, Christa L de Winter, Gert-Jan B van Ommen, Judith C T van Deutekom, Annemieke Aartsma-Rus

Ann N Y Acad Sci· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms.
Annemieke Aartsma-Rus, Laura van Vliet, Marscha Hirschi, Anneke A M Janson, Hans Heemskerk, Christa L de Winter

Mol Ther· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
Hans A Heemskerk, Christa L de Winter, Sjef J de Kimpe, Petra van Kuik-Romeijn, Niki Heuvelmans

J Gene Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy.
Laura van Vliet, Christa L de Winter, Judith C T van Deutekom, Gert-Jan B van Ommen, Annemieke Aartsma-Rus

BMC Med Genet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites.
Annemieke Aartsma-Rus, Christa L De Winter, Anneke A M Janson, Wendy E Kaman, Gert-Jan B Van Ommen

Oligonucleotides· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of the interaction between tuberin and 14-3-3zeta.
Mark Nellist, Miriam A Goedbloed, Christa de Winter, Brenda Verhaaf, Anita Jankie

J Biol Chem· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis